SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
Developed in collaboration with Memorial Sloan Kettering Cancer Center, MSK-ACCESS® powered with SOPHiA DDM™ is an innovative liquid biopsy testing application designed to detect actionable genomic alterations from a single blood draw using proprietary, state-of-the-art algorithms which analyze circulating tumor DNA (ctDNA). The application supports real-time cancer monitoring and treatment selection when traditional tissue biopsies are not feasible due to cost, turnaround time, insufficient tissue, or the invasiveness of the procedure.
The expanded rollout will continue to contribute to AstraZeneca's global real-world evidence initiatives and help further validate the clinical impact of decentralized liquid biopsy testing across diverse healthcare systems. By increasing the availability of MSK-ACCESS® powered with SOPHiA DDM™, SOPHiA GENETICS and AstraZeneca aim to understand further how liquid biopsy testing can complement solid tissue testing and, in some cases, provide greater benefit for labs and patients.
The announcement coincides with SOPHiA GENETICS's presentation at AACR, in which the company presented data demonstrating the robust transferability of the decentralized MSK-ACCESS® powered with SOPHiA DDM TM solution. Historically, site-to-site discordance has been a major barrier to the widespread adoption of liquid biopsy testing. SOPHiA GENETICS presented real-world data highlighting the consistent accuracy and precision of MSK-ACCESS® powered with SOPHiA DDM TM across various laboratory settings. Interim results from the multi-center study demonstrated the high analytical performance of the decentralized test in line with the original single-site test at Memorial Sloan Kettering Cancer Center in New York.
"Our collaboration with AstraZeneca represents a significant step toward scaling next-generation oncology diagnostics globally," said Ross Muken, President, SOPHiA GENETICS. "This expanded deployment reflects the growing momentum behind liquid biopsy and our shared ambition to make these technologies more accessible and impactful worldwide."
Visit SOPHiA GENETICS at the American Association for Cancer Research's Annual Meeting in Chicago, Illinois from April 25 th –30 th to learn more about how SOPHiA GENETICS is collaborating with AstraZeneca to transform patient care with data-driven medicine.
For more information on SOPHiA GENETICS, visit SOPHiAGENETICS.COM, or connect on LinkedIn.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDM™ Platform, which analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. The information in this press release is about products that may or may not be available in different countries and, if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact [email protected] to obtain the appropriate product information for your country of residence.
SOPHiA GENETICS Forward-Looking Statements:
This press release contains statements that constitute forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations and financial position, business strategy, products, and technology, as well as plans and objectives of management for future operations, are forward-looking statements. Forward-looking statements are based on our management's beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including those described in our filings with the U.S. Securities and Exchange Commission. No assurance can be given that such future results will be achieved. Such forward-looking statements contained in this press release speak only as of the date hereof. We expressly disclaim any obligation or undertaking to update these forward-looking statements contained in this press release to reflect any change in our expectations or any change in events, conditions, or circumstances on which such statements are based, unless required to do so by applicable law. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
37 minutes ago
- Globe and Mail
WKHS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Workhorse Group Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Workhorse Group Inc. (NASDAQ: WKHS) and Motiv Electric Trucks is fair to Workhorse shareholders. Upon completion of the proposed transaction, Workhorse shareholders will own approximately 26.5% of the combined company. Halper Sadeh encourages Workhorse shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@ or zhalper@ The investigation concerns whether Workhorse and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Workhorse shareholders; and (2) disclose all material information necessary for Workhorse shareholders to adequately assess and value the merger consideration. On behalf of Workhorse shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome.
Globe and Mail
an hour ago
- Globe and Mail
1 Reason to Buy Robinhood Markets (HOOD) Stock
Key Points Robinhood is attracting new customers at a rapid clip. Revenue grew 45% in Q2, yet Robinhood still offers a limited range of services compared to big brokers. As it continues to roll out new features, Robinhood could see an avalanche of asset growth. 10 stocks we like better than Robinhood Markets › Robinhood Markets (NASDAQ: HOOD) is breaking a new mold in the fintech market. The stock has rocketed 490% higher over the past year, sending its market cap toward $100 billion. While the stock might look overbought after such a steep rally, its customer assets are still very small compared to other leading financial service companies, which leaves plenty of room for the company (and stock) to grow in value over the long term. The more services Robinhood brings customers, the more it grows Robinhood's platform assets have increased from $89 billion in the second quarter of 2023 to $279 billion in Q2 2025. With fee-generating services like Robinhood Gold continuing to gain traction, revenue grew 45% year over year in the second quarter to $989 million. This is why the stock is still a buy at these highs. Robinhood is seeing this much growth while offering limited services compared to big brokers like Schwab. As it catches up, Robinhood could grow into a multitrillion-dollar financial services company. Robinhood's pace of new announcements has been remarkable. In the first quarter, it rolled out index options to all customers, and it followed that up in the second quarter with the launch of stock tokens in Europe, allowing those customers to trade over 200 U.S. stocks in the form of tokenized contracts on a blockchain. By the end of the third quarter, Robinhood plans to launch its new banking service too. These are just a few of the many announcements the company has made recently. As it continues to launch new trading products, including its Cortex AI -powered trading tool later this year, its platform assets will likely continue to grow. There are several products, including fixed-income securities, that Robinhood can eventually tap into to further support its growth. For perspective, Schwab has over $10 trillion in client assets. I wouldn't bet against Robinhood CEO Vlad Tenev's ability to grow Robinhood into one of country's largest brokerage services. The stock still offers tremendous long-term upside. Should you invest $1,000 in Robinhood Markets right now? Before you buy stock in Robinhood Markets, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Robinhood Markets wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,155!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,106,071!* Now, it's worth noting Stock Advisor's total average return is 1,070% — a market-crushing outperformance compared to 184% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Charles Schwab is an advertising partner of Motley Fool Money. John Ballard has positions in Robinhood Markets. The Motley Fool recommends Charles Schwab and recommends the following options: short September 2025 $92.50 calls on Charles Schwab. The Motley Fool has a disclosure policy.
Globe and Mail
2 hours ago
- Globe and Mail
2 Soaring Tech Stocks to Buy and Hold for the Next Decade
Key Points Microsoft is well on its way to dethroning Amazon in the ever-expanding cloud market. Oracle's autonomous database business is booming, and it sees further room for growth. 10 stocks we like better than Microsoft › Investors looking for winning stock ideas for the next decade need to look no further than the companies enabling artificial intelligence (AI) adoption. The recent financial results of leading companies serving the cloud computing market show that enterprise investment in AI is still in the early stages. Here are two stocks to profit from this opportunity. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » 1. Microsoft Microsoft (NASDAQ: MSFT) is the 800-pound gorilla in the cloud services market. While Amazon continues to control the top spot in market share, Microsoft Azure is growing faster and is on pace to eventually overtake the No. 1 position in the cloud market. Microsoft stock is up 26% year to date. Azure and other cloud services from Microsoft posted a 39% year-over-year increase in revenue for the fiscal fourth quarter (which ended in June). Management credits its growing footprint of over 400 data centers in 70 regions around the world for its momentum. The company is further bolstering its competitive position with tools like Microsoft Fabric. This is a data and analytics platform that is rapidly expanding. Revenue grew 55% year over year last quarter, indicating that Microsoft is positioned to capture demand for AI-driven database services. Microsoft generates $281 billion in annual revenue right now, yet management noted that there is $368 billion worth of contracted backlog across its cloud business. With a company this large growing earnings per share at 24% year over year in the recent quarter, it's possible that Wall Street is still underestimating the size of the AI opportunity. Analysts are projecting low-double-digit earnings growth over the next few years, but that might be underestimating the company's opportunity. Microsoft has delivered excellent returns for investors for many years, and that streak doesn't appear to be ending anytime soon. 2. Oracle Oracle (NYSE: ORCL) is another top tech stock to ride the growing investment in cloud services. Oracle's Cloud Infrastructure business is experiencing explosive growth, which sent the stock to new highs after its fiscal Q4 earnings report in June. "In Q4, we hit double-digit revenue growth and it's only going up from here," CEO Safra Catz said during the earnings call. Oracle has been building up its cloud offering for over a decade, and it's paying off. Companies are choosing Oracle for its market-leading database services to leverage autonomous features. Autonomous database consumption revenue grew 47% year over year, accelerating from 27% growth in the year-ago quarter. Beginning in fiscal 2026, management expects growth to accelerate. Company guidance calls for total cloud revenue growth to be over 40% in constant currency, with cloud infrastructure growth of over 70%, which includes the autonomous database business. Oracle is playing an important role in enabling the AI revolution across the economy. This is evidenced by its participation in the Stargate Project with OpenAI, which aims to build state-of-the-art AI infrastructure in the U.S. The revenue expected from Stargate should at least marginally contribute to Oracle's growth over the next decade. For what it's worth, Wall Street analysts expect Oracle's adjusted (non-GAAP) earnings to grow at an annualized rate of 19% through fiscal 2030. Oracle is an industry-leading cloud database provider with a large suite of enterprise applications. It has a long history of delivering solid returns to investors, with the stock up over 500% in the last decade. With growth accelerating due to AI, it should continue to reward shareholders. Should you invest $1,000 in Microsoft right now? Before you buy stock in Microsoft, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Microsoft wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,155!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,106,071!* Now, it's worth noting Stock Advisor's total average return is 1,070% — a market-crushing outperformance compared to 184% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 John Ballard has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon, Microsoft, and Oracle. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
